Indian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations.

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...

After years of preparation, Eli Lilly is on the brink of launching ... The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device ...

In November 2022, the launch of a diabetes platform that tracks blood sugar, and insulin pen use announced by Eli Lilly. North America held the Dominant Position: Technological Advancement to ...

Danish couple August and Marie Krogh founded Nordsik Insulinlaboratorium in 1923 and commercialized the production of insulin ... and UK regulators approved Eli Lilly's rival weight-loss treatment ...

(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to ...

NPH is administered with an insulin pen or syringe to the stomach, thighs, or upper arms. Humulin N is one brand of NPH insulin produced by Eli Lilly and Company, and Novo Nordisk makes Novolin N.